RGLS

Regulus Therapeutics
RGLS

Overview Fund Activity
Delisted

RGLS was delisted on the 24th of June, 2025.

Back to rankings

27 hedge funds and large institutions have $11.1M invested in Regulus Therapeutics in 2022 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 1 closing their positions.

Holders
27
Holders Change
+3
Holders Change %
+12.5%
% of All Funds
0.44%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
5
Reduced
7
Closed
1
Calls
$956K
Puts
$2K
Net Calls
+$954K
Net Calls Change
-$184K

Top Buyers

1
Citadel Advisors
1
Citadel Advisors
Florida
$58.2K
2
TRCT
2
Tower Research Capital (TRC)
New York
$10K
3
Geode Capital Management
3
Geode Capital Management
Massachusetts
$102K
4
Renaissance Technologies
4
Renaissance Technologies
New York
$48K
5
Vanguard Group
5
Vanguard Group
Pennsylvania
$387K

Top Sellers

1
HF
1
HRT Financial
New York
$0
2
Commonwealth Equity Services
2
Commonwealth Equity Services
Massachusetts
$23K
3
UBS Group
3
UBS Group
Switzerland
$7.76K
4
BlackRock
4
BlackRock
New York
$61.2K
5
Group One Trading
5
Group One Trading
Illinois
$10K
Name Market Value Shares Shares
Change 		Shares
Change %
Rockefeller Capital Management
26
Rockefeller Capital Management
New York
$0 1 – –
Susquehanna International Group
27
Susquehanna International Group
Pennsylvania
– – – –
CFGS
28
Concourse Financial Group Securities
Alabama
– – – –
Parallax Volatility Advisers
29
Parallax Volatility Advisers
California
– – – –
Osaic Holdings
30
Osaic Holdings
Arizona
$0 50 – –
Simplex Trading
31
Simplex Trading
Illinois
$0 301 +301 New
1
2